Protein Fusion Extends Drug Half-Life Technology

Using fusion expression technology, CD Formulation is able to modify marketed cytokines to develop a steady stream of new, superior products. As a leading fusion protein technology services company, we have years of experience in long-acting protein-based drugs.

• Supplier: CD Formulation
• Product #: S-MSMN-043